NeuroPace (NPCE) News Today $8.99 +0.37 (+4.29%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$9.04 +0.05 (+0.56%) As of 08/22/2025 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NPCE Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period NeuroPace, Inc. (NASDAQ:NPCE) Given Average Recommendation of "Moderate Buy" by BrokeragesAugust 21 at 8:26 AM | marketbeat.com466,015 Shares in NeuroPace, Inc. (NASDAQ:NPCE) Acquired by Lord Abbett & CO. LLCAugust 19, 2025 | marketbeat.comQ3 Earnings Estimate for NeuroPace Issued By HC WainwrightAugust 19, 2025 | marketbeat.comFinancial Contrast: NeuroPace (NASDAQ:NPCE) and Disaboom (OTCMKTS:MEDH)August 18, 2025 | americanbankingnews.comQ1 Earnings Forecast for NeuroPace Issued By HC WainwrightAugust 17, 2025 | marketbeat.comCantor Fitzgerald Lifts Earnings Estimates for NeuroPaceAugust 17, 2025 | marketbeat.comFY2025 EPS Forecast for NeuroPace Increased by AnalystAugust 17, 2025 | marketbeat.comQ1 Earnings Estimate for NeuroPace Issued By HC WainwrightAugust 17, 2025 | americanbankingnews.comNeuroPace FY2029 EPS Estimate Boosted by Leerink PartnrsAugust 16, 2025 | marketbeat.comDeutsche Bank AG Grows Position in NeuroPace, Inc. (NASDAQ:NPCE)August 16, 2025 | marketbeat.comWells Fargo & Company Has Lowered Expectations for NeuroPace (NASDAQ:NPCE) Stock PriceAugust 15, 2025 | marketbeat.comNeuroPace (NASDAQ:NPCE) Given New $15.00 Price Target at Wells Fargo & CompanyAugust 15, 2025 | americanbankingnews.comNeuroPace (NASDAQ:NPCE) Announces Quarterly Earnings ResultsAugust 14, 2025 | marketbeat.comNeuroPace, Inc. (NASDAQ:NPCE) Q2 2025 Earnings Call TranscriptAugust 13, 2025 | insidermonkey.comNeuroPace Reports Record Revenue and Raises GuidanceAugust 13, 2025 | msn.comEarnings To Watch: NeuroPace Inc (NPCE) Reports Q2 2025 ResultAugust 12, 2025 | finance.yahoo.comNeuroPace: On track to submit Nautilus data to FDA in 2HAugust 12, 2025 | msn.comNeuroPace, Inc. (NPCE) Q2 2025 Earnings Call TranscriptAugust 12, 2025 | seekingalpha.comNeuroPace Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue GuidanceAugust 12, 2025 | globenewswire.comNeuroPace (NPCE) Projected to Post Earnings on TuesdayAugust 6, 2025 | marketbeat.comNeuroPace, Inc.: NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator CasesAugust 1, 2025 | finanznachrichten.deNeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator CasesAugust 1, 2025 | globenewswire.comEssex Investment Management Co. LLC Acquires Shares of 138,426 NeuroPace, Inc. (NASDAQ:NPCE)July 30, 2025 | marketbeat.comLegato Capital Management LLC Takes Position in NeuroPace, Inc. (NASDAQ:NPCE)July 26, 2025 | marketbeat.comNeuroPace’s SWOT analysis: innovative epilepsy treatment stock faces growth hurdles - Investing.comJuly 8, 2025 | investing.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. ...July 6, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCEJuly 2, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCEJune 27, 2025 | prnewswire.comNeuroPace Announces Strategic CFO Transition - MorningstarJune 26, 2025 | morningstar.comMNeuroPace, Inc.: NeuroPace Announces Strategic CFO TransitionJune 25, 2025 | finanznachrichten.deINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCE - MorningstarJune 24, 2025 | morningstar.comMNeuroPace Announces Strategic CFO TransitionJune 24, 2025 | globenewswire.comNPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law FirmJune 24, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCEJune 23, 2025 | globenewswire.comPalumbo Wealth Management LLC Has $567,000 Holdings in NeuroPace, Inc. (NASDAQ:NPCE)June 23, 2025 | marketbeat.comNPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law FirmJune 22, 2025 | gurufocus.comNPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law FirmJune 22, 2025 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. ...June 22, 2025 | gurufocus.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCEJune 22, 2025 | prnewswire.comNeuroPace, Inc. (NASDAQ:NPCE) Given Consensus Rating of "Moderate Buy" by BrokeragesJune 22, 2025 | marketbeat.comNeuroPace, Inc. (NPCE) Backed by Cantor Fitzgerald Following Physician SurveyJune 17, 2025 | msn.comNeuroPace’s SWOT analysis: med tech stock poised for growth amid challengesJune 14, 2025 | investing.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCEJune 12, 2025 | prnewswire.comTwo Sigma Investments LP Makes New Investment in NeuroPace, Inc. (NASDAQ:NPCE)June 11, 2025 | marketbeat.comCantor Fitzgerald Comments on NeuroPace FY2026 EarningsJune 10, 2025 | marketbeat.comQ2 Earnings Forecast for NeuroPace Issued By Leerink PartnrsJune 9, 2025 | marketbeat.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCEJune 7, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeuroPace, Inc. - NPCEJune 6, 2025 | globenewswire.comNeuroPace, Inc. Secures $75 Million Credit Facility from MidCap Financial to Support Growth InitiativesJune 5, 2025 | nasdaq.comNeuroPace Secures $75 Million Credit Facility with MidCapJune 4, 2025 | tipranks.com Get NeuroPace News Delivered to You Automatically Sign up to receive the latest news and ratings for NPCE and its competitors with MarketBeat's FREE daily newsletter. Email Address NPCE Media Mentions By Week NPCE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NPCE News Sentiment▼0.850.69▲Average Medical News Sentiment NPCE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NPCE Articles This Week▼144▲NPCE Articles Average Week Get NeuroPace News Delivered to You Automatically Sign up to receive the latest news and ratings for NPCE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BioLife Solutions News MiMedx Group News Establishment Labs News Pulse Biosciences News InMode News iRadimed News Tandem Diabetes Care News Kestra Medical Technologies News Embecta News SiBone News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NPCE) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroPace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroPace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access